Teva Pharmaceutical

New pharma CEOs to face payer, pricing challenges
New pharma CEOs to face payer, pricing challenges
Medical Marketing and Media
Pharma CEOs
Novartis
Teva Pharmaceutical
Kåre Schultz
Vasant Narasimham
payers
drug pricing
Flag link:
Teva CEO gets lots of advice on how to fix beleaguered company, even before he begins
Teva CEO gets lots of advice on how to fix beleaguered company, even before he begins
Fierce Pharma
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
Flag link:
States Push Ahead With Investigation Into Opioid Painkillers
States Push Ahead With Investigation Into Opioid Painkillers
FOX Business
opioids
opioid crisis
Endo International
Janssen
Allergan
Teva Pharmaceutical
Purdue Pharma
Flag link:
Troubled Teva turns to risk-sharing team at Nuvelution to gamble on a new PhIII study
Troubled Teva turns to risk-sharing team at Nuvelution to gamble on a new PhIII study
Endpoints
Teva Pharmaceutical
Nuvelution
R&D
Flag link:
Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?
Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?
Motley Fool
Halozyme
Inovalon
Teva Pharmaceutical
Unitedhealthcare Group
Roche
Bristol-Myers Squibb
Flag link:
Cash-strapped Teva closes in on women's health sale No. 2: report
Cash-strapped Teva closes in on women's health sale No. 2: report
Fierce Pharma
Teva Pharmaceutical
Women's Health
M&A
CVC
Flag link:
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid
Fierce Pharma
Teva Pharmaceutical
executive pay
Pharma CEOs
Lundbeck
Kåre Schultz
Flag link:
Teva makes good on asset-sale vows with $1.1B contraceptive sale
Teva makes good on asset-sale vows with $1.1B contraceptive sale
Fierce Pharma
Teva Pharmaceutical
CooperSurgical
M&A
contraceptives
Paragard
IUD
Flag link:
Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn’t refuse, including $20M in cash
Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn’t refuse, including $20M in cash
Endpoints
Teva Pharmaceutical
Lundbeck
Pharma CEOs
Kåre Schultz
Flag link:
A Perfect Storm Cut Teva Pharmaceutical Industries's Stock in Half in August
A Perfect Storm Cut Teva Pharmaceutical Industries's Stock in Half in August
Motley Fool
Teva Pharmaceutical
earnings
Flag link:
Allergan-Restasis Patent Battle Could Test Lawmakers' Resolve
Allergan-Restasis Patent Battle Could Test Lawmakers' Resolve
NY Shock Exchange
Allergan
Restasis
patents
Mylan Labs
Pfizer
Teva Pharmaceutical
Shire
Flag link:
Teva takes on Neurocrine with TD nod for Austedo
Teva takes on Neurocrine with TD nod for Austedo
Fierce Pharma
Teva Pharmaceutical
Neurocrine
Austedo
tardive dyskinesia
FDA
Flag link:
Allergan heads to federal court to defend Restasis against early generic rivals
Allergan heads to federal court to defend Restasis against early generic rivals
Fierce Pharma
Allergan
Restasis
generics
Mylan Labs
Teva Pharmaceutical
Akorn
InnoPharma
Flag link:
Bidders line up for Teva's women's health unit in potential $2B sale
Bidders line up for Teva's women's health unit in potential $2B sale
Fierce Pharma
Teva Pharmaceutical
M&A
Women's Health
Flag link:
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Fierce Pharma
multiple sclerosis
MS
drug pricing
Bayer
Biogen
Merck KGaA
Novartis
Sanofi
Teva Pharmaceutical
Roche
Flag link:
Teva Must Clear Three Big Hurdles to Reclaim Its Perch
Teva Must Clear Three Big Hurdles to Reclaim Its Perch
TheStreet.com
Teva Pharmaceutical
Flag link:
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Flag link:
Teva kept quiet for weeks on forthcoming generics blow: report
Teva kept quiet for weeks on forthcoming generics blow: report
Fierce Pharma
Teva Pharmaceutical
generics
Flag link:
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
GoInPharma
Teva Pharmaceutical
M&A
Respiratory
Women's Health
oncology
Medis
Flag link:
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Fierce Pharma
Mylan Labs
FDA
Advair
Copaxone
generics
Teva Pharmaceutical
GSK
Flag link: